Search Results - "Journal of clinical and translational hepatology"
-
1
Elevated Liver Enzymes in Asymptomatic Patients – What Should I Do?
Published in Journal of clinical and translational hepatology (28-12-2017)Get full text
Journal Article -
2
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
Published in Journal of clinical and translational hepatology (28-11-2023)“…To facilitate the achieving of the goal of "eliminating viral hepatitis as a major public health threat by 2030" set by the World Health Organization, the…”
Get full text
Journal Article -
3
Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review
Published in Journal of clinical and translational hepatology (15-06-2015)Get full text
Journal Article -
4
Guidelines for Prevention and Treatment of Chronic Hepatitis B
Published in Journal of clinical and translational hepatology (28-10-2021)“…To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major public health threat by 2030, the Chinese Society of Infectious…”
Get full text
Journal Article -
5
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
Published in Journal of clinical and translational hepatology (28-04-2023)“…Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial…”
Get full text
Journal Article -
6
Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India
Published in Journal of clinical and translational hepatology (28-12-2021)“…The impact of coronavirus disease-2019 (COVID-19) on liver function remains to be fully elucidated. This study was designed to investigate such and determine…”
Get full text
Journal Article -
7
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD
Published in Journal of clinical and translational hepatology (28-10-2022)“…The pathogenesis of metabolic-associated fatty liver disease (MAFLD) is complex and thought to be dependent on multiple parallel hits on a background of…”
Get full text
Journal Article -
8
Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update
Published in Journal of clinical and translational hepatology (28-12-2021)“…Liver fibrosis is a life-threatening disease, with challenging morbidity and mortality for healthcare systems worldwide. It imparts an enormous economic burden…”
Get full text
Journal Article -
9
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies
Published in Journal of clinical and translational hepatology (28-03-2020)“…The outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has attracted increasing…”
Get full text
Journal Article -
10
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease
Published in Journal of clinical and translational hepatology (28-12-2021)“…Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is currently the most common chronic liver disease and affects at least a quarter of the global…”
Get full text
Journal Article -
11
Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota
Published in Journal of clinical and translational hepatology (28-08-2023)“…Non-alcoholic fatty liver disease (NAFLD) is closely associated with gut microbiota and has become the most common chronic liver disease worldwide, but the…”
Get full text
Journal Article -
12
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
Published in Journal of clinical and translational hepatology (28-04-2022)“…Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents with a wide spectrum of extrahepatic manifestations, such as…”
Get full text
Journal Article -
13
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study
Published in Journal of clinical and translational hepatology (28-02-2022)“…Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new concept, proposed in 2020; however, its applicability in Asia populations has yet to be…”
Get full text
Journal Article -
14
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease
Published in Journal of clinical and translational hepatology (28-03-2020)“…An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (2019 coronavirus disease, COVID-19) since December 2019, from Wuhan,…”
Get full text
Journal Article -
15
Statin-induced Liver Injury Patterns: A Clinical Review
Published in Journal of clinical and translational hepatology (28-06-2022)“…Since their introduction in 1987, hydroxymethyl glutaryl coenzyme A reductase (HMG-CoA) inhibitors, more commonly known as statins, have become some of the…”
Get full text
Journal Article -
16
The Gut Microbiome and Ferroptosis in MAFLD
Published in Journal of clinical and translational hepatology (01-01-2023)Get full text
Journal Article -
17
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review
Published in Journal of clinical and translational hepatology (28-02-2022)“…Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, is known for its grim prognosis, with untreated life expectancy being only a…”
Get full text
Journal Article -
18
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy
Published in Journal of clinical and translational hepatology (28-02-2022)“…The proportions of patients with hepatocellular carcinoma (HCC) involving portal vein tumor thrombus (PVTT) varies greatly in different countries or regions,…”
Get full text
Journal Article -
19
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome
Published in Journal of clinical and translational hepatology (28-06-2022)“…Background and AimsThe effect of ginsenoside Rb1 on D-galactosamine (D-GalN)/lipopolysaccharide (LPS)-induced acute liver injury (ALI) is unknown. The aim of…”
Get full text
Journal Article -
20
Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 2019
Published in Journal of clinical and translational hepatology (28-04-2021)Get full text
Journal Article